Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias

Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias

US Patent 11246871 · Granted Feb 15, 2022

Estimated economic value: $128,307,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dihydropyridine compositions and methods for treating neurological disorders2023
Compositions and methods to reduce pharmaceutical-induced toxicity2023
Selective calcium channel antagonists2018
Treatment of Levodopa-induced Dyskinesias2018
Treatment of Levodopa-induced Dyskinesias2018
Treatment for dopaminergic disorders2016
Selective calcium channel antagonists2016